Course Description:
This course provides the active intermediate-to-advanced clinician with a comprehensive review of the science of HIV, Hepatitis and COVID, as well as an update on the application of HIV, Hepatitis and COVID therapies. For ambitious new clinicians who want a challenge, we will still offer our New Clinicians Track (NCT). This track provides five additional lectures that covers antiretroviral therapy (ART) 101, basic HIV pharmacology, ART resistance, IRIS, and opportunistic infections. All course lecturers are leading clinicians and teachers who are dedicated to teaching in their areas of expertise.

The COVID pandemic has further amplified existing health disparities as well as the vulnerability of our patients, making the need for up-to-date information about HIV/AIDS, Hepatitis and COVID essential for providing high quality care. Transmission, diagnosis, treatment, unusual manifestations, and communities at high-risk of COVID will be covered thoroughly. All lectures will be cased-based with at least 2-4 active ARS questions per lecture. Question and answer periods are weaved into each conference day along with a debate (Day 1) and panel (Day 3) dedicated to controversies in ART management (including PrEP). This format is designed so that you can privately test your individual ART knowledge against the experts throughout the conference.

Target Audience
This course is designed for practicing internists, family practice physicians, infectious disease specialists, nurse practitioners, physician assistants and pharmacists, and will focus on the breadth of practical issues in the care of people living with HIV/AIDS, Hepatitis and COVID.

Live Stream Meeting
This course will be offered as a virtual conference. Login instructions along with the digital syllabus will be shared with the attendees a week before the meeting. Included in your registration fee is access to the Course Recordings within one week after the conference ends and your Course Evaluation is complete. These Course Recordings will remain accessible for an additional 60 days.